NERV

NASDAQ open

Minerva Neurosciences

2.03 USD
▼-0.09-4.25%
盘后 2.31 0.00%
2026-11-20
市值
$99.67M
市盈率
—
EPS
-8.44
股息率
—
52 周区间
1.96 – 8.80
成交量
73.83K
Beta
0.01
目标价
10.33
52W 低 1.9652W 高 8.80
价格走势

公司简介

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, which is in Phase 3 confirmatory trial for the treatment of negative symptoms in patients with schizophrenia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.